Another brick out of the wall 
1 Like
What would people’s ideal sell price be on these? Relatively new to it and just gradually topping up little by little, but interest to know how far we think this can go with all of the positives generally for the WW and european markets
1 Like
Welcome pal. Hardest question in the game that one.? I genuinely have no idea. They need a lot of things to fall their way and in to line, but if they do and the way the world going with cbd it could go well. What would you want it to sell at?
Im not going to entertain the thought of selling over the next five years unless they are bought out or I have to.
At the end of 2021 the cannabis bubble burst on no legislation and every green leaf stock took a behemothic dive off a cliff. Then qgain off another cliff, then again… etc.
Fast forward to January 2024 and europe is opening up, the UK is hugely strong for medical cannabis and KNB have the only farm to pharmacy company in the game (Geoff?).
I have no interest in speculating on share price target as I would undoubtedly miss something. But I am confident that KNB are suitably well placed in business, financial (Mattioli) and political (Cannabis Industry Council) that means when things start happening KNB will be there.
Maybe that was a better question, how long are people expecting to hold them for. I guess I don’t have a price in mind as they are so cheap, looking to just buy penny stocks every time I think about gambling haha. Thought medicinal cannabis was a good way to go as an emerging product, feels like sky is the limit
3 Likes
I think it was a great question. At present, it is very difficult to quantify share price value because the medical cannabis industry across the globe is so new. That drives my five year thesis. And the past two years have been a complete sell off. But it is all macro and reflective of the apetitie for investment in general and especially related to new industries. My confidence is backed up by the fact that the clogs in the political channels are quite clearly being cleared almost daily now and Kanabo as a company are doing very indeed. I would also say that even though the channels are being cleared bumps in the road not only expected but essential - take legislation in Germany, pushed back from January 2024 to April 2024.
You are spot on though, KNB is cheap and Im happy to keep buying whilst no one is looking
Cannabis is an unusual investment in that it’s a relatively new and emerging market which has 100 years of baggage weighing it down because of prohibition.
To me stigma is the greatest barrier to overcome for KNB to reach its potential so a change in the way cannabis is presented to the public by the authorities is required. Even CBD is still very much under the radar when it comes to public awareness of it and how potent a medicine it is.
I am referring to the UK here because I don’t think the same issue exists across Europe so I would look to the granting of the CE mark and Germany opening up as a major event in establishing a strong market presence.
All being well I think we should be in a much better price range in six months but I could only make a guess as to how much. As to how long to hold, again if they gain a strong foothold in the market then I would hold long and expect this to be a multi bagger.
Far better to back KNB than putting on a horse 
1 Like
2 Likes
In the past I used it at work when arthritis prevented me doing my job, a good dose of the right strain would have me powered up for hard graft for hours. It’s about time the stonners myth was dispelled.
3 Likes
While not immediately effecting kNB this is good news for anyone involved in the cultivation of hemp/CBD in the UK.
2 Likes
Another interesting day. Massive volume compared to yesterday. It’s weird how it fluctuates. Although we’re well into the countdown for the contract announcement on 24th. Fingers crossed it’s good news for us.
3 Likes
Just wondering how much I can top up before then. These a now a large part of my portfolio
1 Like
This is 100% of my holdings at the moment. Not got a lot of money invested. Only dabble on freetrade with petty cash tbh. Got bored with the other bits I was playing around with so have pooled the lot here for a gamble. Run the risk I lose it all but I’m happy to take that for the potential returns. Might add a little more this week if it dips again.
2 Likes
I am all in here as well, the fact is we are seeing the renaissance of herbal medicine with cannabis as the vanguard. The quality and depth of knowledge of the directors of KNB is very high calibre in my opinion.
The business model, although I initially bought in on the basis of the vape pod the way the company has developed shows great savvy as to the emerging medical CBMP market.
This will be a good year IMHO
2 Likes
We have been told for years how cannabis causes psychosis, remember Gordon Brown when he reclassified cannabis after saying he had seen the damage done while he was a student. Mind you he used to down eight pints while out with his rugby team mates so probably not seeing too clearly. Anyhow it turns out it was more gaslighting from politicians on the subject of cannabis.
5 Likes
At what point would analysts review an estimate on products. You see a lot with but many without on this app specifically?
We could see a steady rise this week in anticipation of the digital pathways tendering news. Shares looked to be in short supply during Friday’s trading and we know how this can move when there is demand. Traders will want back in helping to drive the SP north.
Well a positive outlook never hurts 
4 Likes
Well, I’d be delighted if your prognosis bears out. I’d also be nonplussed if this current rise is not news based but just a bit of a common sense reversal of the last two years. I’d love to know what fair share price to NAV is. Two years ago, before Treatit (GP teleservice), the farm in Portugal, the research department or they owned a stake in HELD the share price was 8p-10p (when I bought in) then the macro environment became war and pestilence.
In any case, fast forward two years with analysts talking positively about interest rates and M&A activity being a hot topic I think even without news it is clear equities are looking a better long term deal than savings accounts and of course the FTSE is the Poundland of the world’s stock market - and if you are looking at a solid business and debt repayment structure with light years of growth ahead… By which I mean that irrespective of news I think the steady rise is a macro reaction. We could of course both be right. I like that version also.
2 Likes